The main objective was to establish suited analytical targets by analyzing human hepatocyte incubation samples with substantial-resolution mass spectrometry (HRMS) and to verify the final results in genuine urine specimens and to ascertain AB-FUBINACA's metabolic steadiness in human liver microsomes and when compared hepatocyte and urine results wi